...
首页> 外文期刊>Der chemica Sinica >Blood lipid levels and aryl esterase activity of alloxan-induced diabetic rats: effects of 2 weeks omega-3 fatty acid supplementation
【24h】

Blood lipid levels and aryl esterase activity of alloxan-induced diabetic rats: effects of 2 weeks omega-3 fatty acid supplementation

机译:四氧嘧啶致糖尿病大鼠的血脂水平和芳基酯酶活性:补充2周omega-3脂肪酸的影响

获取原文
           

摘要

Diabetes mellitus is a complex metabolic disorder associated with chronic hyperglycaemia and hyperglucosuria arising from insulin deficiency. It is accompanied by dyslipidemia, a major risk factor contributing to cardiovascular diseases. Therefore, the effects of omega-3 fatty acid (O3FA) supplement on plasma, erythrocyte and lipoproteins lipid profiles as well as aryl esterase activities in plasma and the lipoproteins of alloxan-induced (150 mg/kg body weight (b.wt), intraperitoneally) diabetic male rats were investigated. O3FA (0.4 g/kg b.wt/day) was administered as pre- and post- treatment for 2 weeks. The blood parameters were measured spectrophotometrically. The lipid levels were significantly increased (p0.05) in the various compartments of the diabetic rats. The increase was from 30% - 107% for cholesterol, 20% - 52% for phospholipid and 38% - 111% for triacylglycerol. Lipid peroxidation was also increased from 67% in extracellular fluid to 164% in the high density lipoprotein (HDL) compartment. O3FA administration significantly reduced (p0.05) the levels of cholesterol, phospholipid and triacylglycerol by varying extents in the various compartments while increasing cholesterol and phospholipid levels in HDL. Lipid peroxidation was significantly reduced (p0.05) by O3FA suggesting that it has protective effect against oxidative damage. Aryl esterase activities in the lipoproteins were also activated by supplementation with O3FA (except in HDL pre-treatment). This study indicates that O3FA supplement attenuates dyslipidemia associated with diabetes mellitus and should be included in diets for prevention and treatment of diabetes mellitus.
机译:糖尿病是由胰岛素缺乏引起的与慢性高血糖症和高糖尿症相关的复杂代谢疾病。它伴有血脂异常,血脂异常是导致心血管疾病的主要危险因素。因此,omega-3脂肪酸(O3FA)补充剂对四氧嘧啶诱导的血浆,红细胞和脂蛋白脂质分布以及芳基酯酶活性和脂蛋白(150 mg / kg体重(b.wt),腹膜内)糖尿病雄性大鼠进行了调查。 O3FA(0.4 g / kg b.wt / day)在治疗前和治疗后2周服用。通过分光光度法测量血液参数。在糖尿病大鼠的各个区室中,脂质水平显着增加(p <0.05)。胆固醇的增加为30%-107%,磷脂的增加为20%-52%,三酰甘油的增加为38%-111%。脂质过氧化也从细胞外液中的67%增加到高密度脂蛋白(HDL)隔室中的164%。施用O3FA可通过不同程度的不同程度显着降低(p <0.05)胆固醇,磷脂和三酰基甘油的水平,同时增加HDL中的胆固醇和磷脂水平。 O3FA使脂质过氧化作用显着降低(p <0.05),表明它具有抗氧化损伤的保护作用。通过补充O3FA也可以激活脂蛋白中的芳基酯酶活性(HDL预处理除外)。这项研究表明,O3FA补充剂可减轻与糖尿病有关的血脂异常,应纳入饮食中,以预防和治疗糖尿病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号